Choreo LLC’s Fortress Biotech FBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$111K Hold
36,250
﹤0.01% 1609
2026
Q1
$101K Hold
36,250
﹤0.01% 1538
2025
Q4
$130K Hold
36,250
﹤0.01% 1496
2025
Q3
$134K Hold
36,250
﹤0.01% 1498
2025
Q2
$67.4K Hold
36,250
﹤0.01% 1477
2025
Q1
$56.5K Sell
36,250
-133
-0.4% -$234 ﹤0.01% 1393
2024
Q4
$73.7K Buy
36,383
+133
+0.4% +$241 ﹤0.01% 1517
2024
Q3
$51.8K Hold
36,250
﹤0.01% 1564
2024
Q2
$61.3K Hold
36,250
﹤0.01% 1431
2024
Q1
$72.5K Hold
36,250
﹤0.01% 650
2023
Q4
$109K Buy
+36,250
New +$95.8K ﹤0.01% 602

Other funds holding FBIO

Choreo LLC's FBIO Position: Q2 2026 in Review

Choreo LLC held its Fortress Biotech (FBIO) position steady in Q2 2026 at 36,250 shares worth $111K. The position accounts for ﹤0.01% of the portfolio, ranked #1609.

Choreo LLC first reported a position in FBIO in Q4 2023 and has held it in 11 quarters since. The position peaked at $134K in Q3 2025. 55 funds tracked by Wall St. Rank hold FBIO as of Q2 2026.

  • Choreo LLC held 36,250 shares of Fortress Biotech worth $111K as of Q2 2026.
  • Choreo LLC left its Fortress Biotech share count unchanged in Q2 2026.
  • Fortress Biotech made up ﹤0.01% of Choreo LLC's portfolio in Q2 2026, its #1609 holding.
  • Choreo LLC first reported a position in Fortress Biotech in Q4 2023 and has held it in 11 quarters since.
  • Choreo LLC's Fortress Biotech position peaked at $134K in Q3 2025.
  • 55 funds tracked by Wall St. Rank held Fortress Biotech as of Q2 2026.

Based on Choreo LLC's 13F filing for Q2 2026, filed 4 Aug 2026.